Skip to main content
Log in

Aldose Reductase: a cause and a potential target for the treatment of diabetic complications

  • Review
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Diabetes mellitus, a disorder of metabolism, results in the elevation of glucose level in the blood. In this hyperglycaemic condition, aldose reductase overexpresses and leads to further complications of diabetes through the polyol pathway. Glucose metabolism-related disorders are the accumulation of sorbitol, overproduction of NADH and fructose, reduction in NAD+, and excessive NADPH usage, leading to diabetic pathogenesis and its complications such as retinopathy, neuropathy, and nephropathy. Accumulation of sorbitol results in the alteration of osmotic pressure and leads to osmotic stress. The overproduction of NADH causes an increase in reactive oxygen species production which leads to oxidative stress. The overproduction of fructose causes cell death and non-alcoholic fatty liver disease. Apart from these disorders, many other complications have also been discussed in the literature. Therefore, the article overviews the aldose reductase as the causative agent and a potential target for the treatment of diabetic complications. So, aldose reductase inhibitors have gained much importance worldwide right now. Several inhibitors, like derivatives of carboxylic acid, spirohydantoin, phenolic derivatives, etc. could prevent diabetic complications are discussed in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Download references

Acknowledgements

The authors acknowledge the support received from the Central University of Punjab, Bathinda, India, in writing this manuscript. VA and PS are grateful to the CSIR, New Delhi, for the award of the fellowship. We thank Subhasmita Mahapatra for reading the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Malkhey Verma.

Ethics declarations

Conflict of interest

The authors declare there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thakur, S., Gupta, S.K., Ali, V. et al. Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. Arch. Pharm. Res. 44, 655–667 (2021). https://doi.org/10.1007/s12272-021-01343-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-021-01343-5

Keywords

Navigation